- $4.62m
- -$13.20m
- 27
- 55
- 28
- 29
Annual income statement for Check Cap, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 14.1 | 13.9 | 17.3 | 20 | 19.3 |
Operating Profit | -14.1 | -13.9 | -17.3 | -20 | -19.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -13.8 | -13.8 | -17.2 | -19.1 | -17.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -13.8 | -13.8 | -17.2 | -19.1 | -17.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -13.8 | -13.8 | -17.2 | -19.1 | -17.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -13.8 | -13.8 | -17.2 | -19.1 | -17.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -693 | -9.12 | -83.1 | -3.37 | -2.76 |